Direct Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.4/10
Best for: listed for disclosure only; see its FDA warning and BBB complaints first
Direct Meds scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Tirzepatide
Price checked on Direct Meds' site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
PartnerDirect Meds is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money
Direct Meds is a telehealth provider offering compounded semaglutide and tirzepatide in injection and sublingual formats. Listed here with full disclosure of a September 2025 FDA warning letter for misleading marketing, plus a documented pattern of customers reporting unexpected 3-month commitment charges. See warnings and cons before considering.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Direct Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $297/mo (starting price)
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter on record; see below
How we scored Direct Meds
Each dimension is scored algorithmically from Direct Meds'published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
5.4/10Direct Meds' headline is $297/mo. Compare it with other programs on the same plan basis.
Effectiveness25%
8.1/10Direct Meds offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.0/10Online intake and platform experience (consult included in the price); 5 platform features disclosed.
Trust & Safety15%
5.2/10Core details confirmed by our editors; an FDA warning letter is on file (see the regulatory notice on this page).
Accessibility10%
6.0/10Direct Meds' exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.8/10Direct Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Direct Meds review
Last checked November 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $249–$399/mo across 4 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with Direct Meds
We walked Direct Meds' public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a free secure online assessment/intake quiz (stated under 5 minutes, no appointments needed).
- 2A licensed U.S. provider reviews your assessment and builds a treatment plan.
- 3Once qualified, your prescription is reviewed and approved within hours.
- 4Approved medication ships within 1-2 business days from a U.S.-certified pharmacy with free tracked delivery.
- The how-it-works page lists pricing before intake (plans start at $249/mo sublingual semaglutide, $297/mo injections); the homepage emphasizes 'no monthly memberships' and 'no hidden fees.'
- Entirely online with 'no appointments needed.'
- The homepage shows 'No Hidden Costs. Ever.' and 'No Membership Fees'; the Terms allow a return when the medication is denied by a Direct Meds doctor.
- Ships within 1-2 business days with free priority/tracked shipping.
- Support via patient-portal messaging, email, and phone during unspecified business hours.
Direct Meds customer support
- Phone
- 888-696-7176
GLP-1 medications Direct Meds offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Direct Meds offers
Beyond GLP-1s, Direct Meds also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Portal shows 'As low as $249.00'; some dosages price as low as $237, on a 90-day supply.
'As low as $297.00 or $9.58 per day', on a 90-day supply shipped at once and billed monthly. 30-, 90-, 180- and 360-day supplies are listed.
'As low as $299.00, or $9.65 per day', on a 90-day supply billed monthly.
'As low as $399.00 or $12.87 per day', on a 90-day supply billed monthly.
Ready to get started?
Plans and promotions change often, so check Direct Meds' current pricing and active discounts before you decide.
What we like
- Semaglutide and tirzepatide available in both injection and sublingual formats
- All-inclusive pricing covers medication, nurse support, digital follow-ups, and free tracked shipping
- LegitScript Certified
- Accepts HSA and FSA payments for all GLP-1 treatments
Watch-outs
- FDA warning letter (Sept 2025) for marketing compounded GLP-1s as equivalent to FDA-approved drugs
- BBB rating 1.12/5 across 226 reviews citing a hidden 3-month commitment (charges of $940+ when buyers expected 1 month)
- Wide rating gap (Trustpilot 4.6/5 vs BBB 1.12/5) points to review-solicitation bias or unresolved complaints
- Not available in Mississippi, Louisiana, or California
- Compounded only: no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- Auto-renews unless you turn off auto-refill 48 hours before the next charge; complaints report long hold times and retention friction
The verdict: a provider we list as a warning, not a recommendation
Direct Meds is a telehealth company selling compounded semaglutide and tirzepatide. We include it here for one reason: so you can see, in plain view, the two things that should give any shopper pause. First, the FDA sent Direct Meds a warning letter in September 2025. Second, its Better Business Bureau profile is full of customers who say they were charged for a three-month supply when they thought they were buying one month. Neither of those is a small footnote. If you read nothing else, read the trust section below before you hand over a card number.
The headline price is $297 a month for sublingual semaglutide, which sits above the category median of $179. On paper the bundle is generous. In practice, the way that bundle gets billed is exactly where the complaints come from.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
How the pricing works, and where it bites
Direct Meds advertises all-inclusive pricing: the medication, nurse support, digital follow-ups, and free tracked shipping are all folded into one number. That part is real and, taken alone, is reasonable. The problem is the structure underneath the number.
- Sublingual semaglutide runs $297 a month, the figure quoted in its marketing.
- Injectable semaglutide is priced a step higher than the sublingual drops.
- Tirzepatide injections sit at the top of its menu; sublingual tirzepatide costs about the same as semaglutide shots.
- Plans auto-renew: you have to turn off auto-refill in the account portal at least 48 hours before the next charge, and the prices are for a 90-day supply shipped at once and billed monthly. At GobyMeds there is no refill setting to remember: you place each order yourself, and nothing is charged until you do.
The recurring theme in BBB reviews is that the advertised monthly figure is not what people were actually charged. Customers describe being billed for a three-month commitment, and one verbatim complaint cites a charge of over nine hundred dollars for a three-month supply the buyer says they never agreed to. Whether you read that as a deliberate trap or a badly disclosed default, the result is the same: the price you see is not reliably the price you pay. Confirm the exact billing terms in writing before you order, and assume the commitment is longer than one month unless told otherwise. Lttl avoids that trap by putting the commitment length next to every price on its public plans page.
The medications: compounded only, in drops or shots
Direct Meds offers both leading GLP-1 molecules, semaglutide and tirzepatide, and, unusually, in both an injectable and a sublingual (under-the-tongue) format. The oral option is the main point of difference for needle-averse patients, since most compounding-focused telehealth sells injections only. MadeMed is another choice here, with a compounded tirzepatide tablet that dissolves under the tongue.
Everything here is compounded. There is no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro on the menu. Compounded GLP-1s are made by outsourcing pharmacies rather than the brand manufacturer, and they are not FDA-reviewed for safety or effectiveness the way the brand drugs are. The company says it holds a LegitScript certification and that licensed third-party compounding pharmacies fill its prescriptions, but it no longer names them. But certification of the storefront is not the same as the FDA standing behind the product in the vial.
The FDA warning letter you should know about
In September 2025 the FDA issued warning letters to 55 online telehealth companies selling compounded GLP-1 drugs, and Direct Meds was one of them. The specific issue cited in its letter was marketing language, including claims like 'same active ingredient as Ozempic and Wegovy' and 'clinically proven ingredients'. The FDA held those to be false or misleading because they imply the compounded product is equivalent to an FDA-approved drug. It isn't.
Beyond the legal technicality, the letter tells you the company was, in the regulator's view, overselling what it ships. When you read the rest of its marketing, read it with that in mind.
The review-score gap nobody should ignore
Direct Meds carries a Trustpilot rating of 4.6 out of 5 across thousands of reviews, and a BBB rating of 1.12 out of 5 across 226 reviews. A gap that wide usually signals heavy review solicitation on one platform and a backlog of unresolved disputes on the other. The BBB complaints cluster tightly around the same story: surprise multi-month charges, auto-renewal that's hard to stop, long hold times, and friction when you try to cancel. When two scoreboards disagree this loudly, the one full of detailed, specific complaints is the one to weight.
Who might consider it, and who should walk
There is a narrow case for Direct Meds: someone who specifically wants a sublingual GLP-1, who reads and accepts a multi-month commitment up front, and who is comfortable with compounded medication despite the FDA's marketing objections. If the oral format is what draws you, Tru2u also sells compounded semaglutide and tirzepatide as tablets, and none of the FDA warning letters we track names it. One caveat: it doesn't name its pharmacy. For most people, the safer move is a provider without a warning letter and without a documented billing-complaint pattern. If you have insurance or can reach the brand drugs, skip compounded entirely. If you value being able to cancel cleanly, the cancellation friction here is a repeated complaint.
Bottom line
Direct Meds bundles a complete GLP-1 program, including a rare oral format, into one all-inclusive monthly price, and it says it holds a LegitScript certification. But a September 2025 FDA warning for misleading marketing, a 1.12-out-of-5 BBB rating built on surprise three-month charges, and an auto-renewal model that's hard to exit add up to a profile we list for disclosure rather than recommend. We score its trust low for exactly these reasons; see our scoring methodology for how that's weighed. If you proceed, get the billing terms in writing first, and treat every marketing claim with skepticism.
The Bottom Line
Direct Meds scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Direct Meds?
From $297/mo. See current pricing and start your online intake.
Direct Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Direct Meds
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare Direct Meds vs…
Direct Meds scores6.4/10
Side-by-side pricing, medications and scores. Pick a matchup.
Direct Meds vs Amazon One Medical
Amazon One Medical scores 8.5/10

Direct Meds vs Vytora Health
Vytora Health scores 8.4/10

Direct Meds vs CoreAge Rx
CoreAge Rx scores 8.3/10

Direct Meds vs Collective
Collective scores 8.3/10

Direct Meds vs Found
Found scores 8.3/10
Direct Meds vs EverSlim
EverSlim scores 8.3/10
All 45 Direct Meds comparisons
- Direct Meds vs AgelessRx
- Direct Meds vs altRX
- Direct Meds vs Belle Health
- Direct Meds vs bmiMD
- Direct Meds vs Bodybuilding Health+
- Direct Meds vs Brightmeds
- Direct Meds vs DudeMeds
- Direct Meds vs Eden
- Direct Meds vs Embody
- Direct Meds vs Enhance MD
- Direct Meds vs Gala
- Direct Meds vs GobyMeds
- Direct Meds vs HealthRX
- Direct Meds vs HumeCare+
- Direct Meds vs Ivim Health
- Direct Meds vs Live Vital
- Direct Meds vs Lttl
- Direct Meds vs Luvo Health
- Direct Meds vs MadeMed
- Direct Meds vs MangoRx
- Direct Meds vs Maximus
- Direct Meds vs MEDGm
- Direct Meds vs MEDVi
- Direct Meds vs Midi Health
- Direct Meds vs NewSelf
- Direct Meds vs Oak
- Direct Meds vs PlexusDx
- Direct Meds vs Ro
- Direct Meds vs RxSpan MD
- Direct Meds vs Sesame Care
- Direct Meds vs ShedRx
- Direct Meds vs SkinnyRx
- Direct Meds vs SnagRx
- Direct Meds vs Sprout Health
- Direct Meds vs Strut Health
- Direct Meds vs TMates
- Direct Meds vs TrimRx
- Direct Meds vs Wellorithm
- Direct Meds vs YourEra
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Direct Meds received an FDA warning letter dated September 9, 2025
The letter concerns unlawful sale of unapproved and misbranded drugs to United States consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Direct Meds review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Direct Meds' current pricing
Plans from $297/mo. Start the online intake to check eligibility and today's price.